vTv Therapeutics Inc

General ticker "VTVT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $86.0M

vTv Therapeutics Inc follows the US Stock Market performance with the rate: 6.7%.

Estimated limits based on current volatility of 3.0%: low 13.89$, high 14.75$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [9.97$, 30.52$]
  • 2023-12-31 to 2024-12-30 estimated range: [5.39$, 17.16$]

Financial Metrics affecting the VTVT estimates:

  • Negative: Non-GAAP EPS, $ of -10 <= 0.10
  • Negative: Operating profit margin, % of -91.78 <= 1.03
  • Negative: Operating cash flow per share per price, % of -21.46 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Net income

Similar symbols

Short-term VTVT quotes

Long-term VTVT plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $6.41MM $4.00MM $2.02MM
Operating Expenses $18.27MM $25.67MM $24.56MM
Operating Income $-11.85MM $-21.66MM $-22.54MM
Non-Operating Income $-0.95MM $4.05MM $-2.33MM
Interest Expense $0.69MM $0.01MM $0.01MM
R&D Expense $11.02MM $13.32MM $12.36MM
Income(Loss) $-12.80MM $-17.62MM $-24.87MM
Taxes $0.00MM $0.12MM $0.20MM
Profit(Loss) $-12.80MM $-17.73MM $-25.07MM
Stockholders Equity $-80.10MM $-9.74MM $-10.74MM
Inventory $0.37MM $0.10MM $0.01MM
Assets $14.79MM $25.47MM $33.24MM
Operating Cash Flow $-18.00MM $-19.31MM $-16.02MM
Capital expenditure $0.00MM $0.00MM $0.02MM
Investing Cash Flow $0.00MM $0.00MM $-0.02MM
Financing Cash Flow $19.47MM $26.98MM $14.75MM
Earnings Per Share* $-7.49 $-11.32 $-13.06

* EPS are Split Adjusted, recent splits may be reflected with a delay.